Core Insights - The report titled "Clinical Chemistry and Immunoassay Industry, Global, 2023-2028" provides an in-depth analysis of the clinical chemistry and immunoassay sector, which holds the largest share in the in vitro diagnostics (IVD) market [1][2] - This sector focuses on lab-based testing of body fluids, primarily blood, urine, or saliva, utilizing various analyzers and assays to aid in the diagnosis and treatment of health conditions [2][3] Market Overview - Clinical chemistry instruments assess different chemicals in body fluids for health evaluation, while immunoassay tests measure analyte concentrations using antibody-antigen binding [3] - The key end-users include hospitals, clinics, diagnostic laboratories, and research institutions, with applications spanning cancer, cardiac, diabetes, infectious diseases, and more [4] Growth Opportunities - The report identifies four primary growth opportunities that leverage current trends to enhance economic potential and sustain value within the sector [4][5] - Key growth drivers include advancements in clinical chemistry and immunoassay technologies, particularly in cardiac applications [5] Revenue Forecasts - The report outlines revenue forecasts segmented by application areas and regions, providing insights into market dynamics and potential growth trajectories [6][8] - Specific growth metrics and revenue share analyses are included to assess the competitive landscape and identify leading players in the market [6][7] Strategic Insights - The report discusses the impact of strategic imperatives on the clinical chemistry and immunoassay industry, highlighting competitive environments and key competitors [7] - It also covers various growth generators across different disease areas, including sepsis, neurology, routine testing, and integrated analyzers [7][8]

Company Performance - Core Laboratories Inc (CLB) shares have risen 11 8% year to date (YTD), outperforming the broader oil and energy sector's 5 6% growth and surpassing competitors like Drilling Tools International Corporation (DTI), Helix Energy Solutions Group, Inc (HLX), and RPC, Inc (RES) [1] - CLB reported a sequential improvement in key financial metrics for Q3 2024, including a 7 2% year-over-year revenue rise and 3% sequential increase to $134 4 million, along with $10 4 million free cash flow generation [4] - The company reduced its debt by $11 8 million, bringing its leverage ratio to the lowest level in six years, highlighting strong financial discipline and a resilient balance sheet [4] Earnings and Growth Potential - The Zacks Consensus Estimate projects CLB's earnings per share to be $0 89 for 2024 and $1 11 for 2025, representing year-over-year growth of 11 25% and 23 97%, respectively [3] - CLB's growth potential is supported by its strong fundamentals, innovative technologies, and alignment with long-term energy trends [3][5][6] Industry Position and Competitive Edge - CLB operates in over 50 countries, providing reservoir management and production enhancement services to oil and gas companies [1] - The company is recognized for its industry-leading technologies, such as the Pulverizor for plug-and-abandonment operations and Flow Profiler diagnostic solutions for unconventional reservoirs, which address cost reduction and operational efficiency challenges [5] - CLB is strategically positioned to benefit from long-term industry trends, including rising global crude oil demand and underinvestment in exploration and development, as forecasted by organizations like OPEC+ and the IEA [6] Market Challenges and Risks - CLB's operations are vulnerable to geopolitical conflicts and extreme weather events, such as Gulf of Mexico hurricanes, which delayed significant projects and temporarily reduced diagnostic services revenues [8] - Weakness in the U S onshore market, driven by low natural gas prices and industry consolidation, has led to a decline in domestic product sales, which may weigh on CLB's overall performance [9] - The company operates in a highly competitive and fragmented market, particularly in the Production Enhancement segment, where pricing power and differentiation are critical [10] - CLB's performance is closely tied to volatile crude oil prices, which could reduce exploration and production activities and impact demand for its services [11] Strategic Outlook - CLB's strong growth potential, solid earnings, healthy balance sheet, and innovative technologies make it an attractive investment in the oilfield services sector [12] - However, investors should remain cautious of risks such as geopolitical instability, oil price volatility, and challenges in the U S onshore market, which could affect future performance [12]

Core Laboratories Overview - Core Laboratories reported Q3 2024 adjusted earnings of 25 cents per share, exceeding the Zacks Consensus Estimate of 21 cents and up from 22 cents in the same quarter last year [2] - Operating revenues for the quarter were $134.4 million, surpassing the Zacks Consensus Estimate of $133 million by 1.1% and increasing 7.5% from $125 million in Q3 2023 [3] Financial Performance - As of September 30, 2024, Core Laboratories' net debt was $120.5 million, a decrease of $11.8 million during the quarter, with a leverage ratio improving to 1.47 from 1.66 [4] - The company had cash and cash equivalents of $21.5 million and long-term debt of $139.9 million, resulting in a debt-to-capitalization ratio of 35.3% [7] Segment Performance - Reservoir Description segment revenues increased 3.5% to $88.8 million, with operating income rising from $13 million to $16.5 million, driven by higher demand for reservoir analysis [5] - Production Enhancement segment revenues grew 13.4% to $45.6 million, although operating income of $3.2 million fell short of projections [6] Future Outlook - For Q4 2024, Core Laboratories expects revenues between $128.5 million and $135.5 million, with earnings per share projected between 20 cents and 25 cents [8] - The company anticipates a multi-year recovery in the international market, with crude oil demand expected to rise by 1-1.6 million barrels per day in 2025 [10][11] Market Conditions - Short-term volatility in crude oil markets is expected due to global economic uncertainties, but long-term project activity in regions like the Middle East and West Africa is anticipated to boost demand for Core Lab's services [12] - U.S. land activity is expected to decline in Q4 2024 but is projected to return to similar levels year-over-year in 2025 [13] Industry Context - Core Laboratories is part of the Zacks Oil and Gas - Field Services industry, where competitors like Schlumberger reported a year-over-year revenue increase of 10.2% [18]

Group 1 - CORE LABS INC (CLB) is experiencing significant activity in the options market, particularly with the Dec 20, 2024 $35.00 Call showing high implied volatility, indicating potential for a major price movement [1] - Implied volatility reflects market expectations for future stock movement, suggesting that investors anticipate a significant event that could lead to a rally or sell-off [2] - Analysts currently rate CORE LABS INC as a Zacks Rank 3 (Hold) within the Oil and Gas – Field Services industry, which is in the bottom 42% of the Zacks Industry Rank, with recent consensus estimates for the current quarter decreasing from 28 cents per share to 25 cents per share [3] Group 2 - The high implied volatility surrounding CORE LABS INC may indicate a developing trading opportunity, as options traders often seek to sell premium on such options to capture decay, hoping the stock does not move as much as expected by expiration [4]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ______________ Commission File Number: 001-41695 CORE LABORATORIES INC. (Exact name of registrant as specified in its charter) Delawar ...

Core Laboratories Inc. (NYSE:CLB) Q3 2024 Earnings Conference Call October 24, 2024 8:30 AM ET Company Participants Larry Bruno - Chairman and Chief Executive Officer Chris Hill - Chief Financial Officer Gwen Gresham - Senior Vice President and Head, Investor Relations Conference Call Participants Sean Mitchell - Daniel Energy Partners Stephen Gengaro - Stifel Operator Good day and welcome to the Core Lab Q3 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instruction ...

Core Laboratories Inc. (CLB) reported third-quarter 2024 adjusted earnings of 25 cents per share, which beat the Zacks Consensus Estimate of 21 cents. The bottom line also increased from the year-ago quarter’s reported figure of 22 cents. This can be attributed to better-than-expected performance from the Reservoir Description and Production Enhancement segments.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.This oilfield service provider’s operating revenues of $134.4 million beat ...

Core Laboratories (CLB) came out with quarterly earnings of $0.25 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.22 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this energy services company would post earnings of $0.21 per share when it actually produced earnings of $0.22, delivering a surprise of 4.76%.Over the last four quarters, the company has surpassed consensus EPS estimates two times.Core Laboratori ...

Exhibit 99.1 FOR IMMEDIATE RELEASE CORE LAB REPORTS THIRD QUARTER 2024 RESULTS: • THIRD QUARTER REVENUE OF $134.4 MILLION, UP 3% SEQUENTIALLY AND OVER 7% YEAROVER-YEAR • THIRD QUARTER OPERATING INCOME OF $19.8 MILLION; EX-ITEMS, $18.2 MILLION, UP 11% SEQUENTIALLY AND 14% YEAR-OVER-YEAR • THIRD QUARTER OPERATING MARGINS, EX-ITEMS, OF 14% UP 100 BPS SEQUENTIALLY • THIRD QUARTER GAAP EPS OF $0.25; EX-ITEMS, $0.25, UP 14% SEQUENTIALLY AND YEAROVER-YEAR • THIRD QUARTER FREE CASH FLOW OF $10.4 MILLION • NET DEBT ...

As the third quarter of 2024 earnings results roll in, oil and energy companies are revealing a mixed bag of outcomes. Despite declining commodity prices, which many analysts thought would weigh heavily on the industry, the results have been better than expected. Several companies have surpassed earnings forecasts, bringing a more optimistic perspective to the sector’s outlook than anticipated. Below, we delve into the current landscape and highlight three stocks — ProPetro Holding Corp. (PUMP) , Core Labor ...